Chairman of the Board of Directors of Aspen Technology, Inc.
Mr. Whelan brings over 35 years of corporate finance and investment banking experience to QR Pharma’s Board of Directors. Since 2001, Mr. Whelan has been President of Whelan & Company, LLC, providing financial consulting, valuation and strategic services to public and private companies in the technology, healthcare and alternative energy industries.
From 1999 to 2001, Mr. Whelan served as Vice Chairman, Prudential Volpe Technology Group, the technology investment banking and research division of Prudential Securities which was formed when Prudential Securities acquired Volpe Brown Whelan & Company in 1999. Prior to then, Mr. Whelan was a senior executive with Volpe Brown Whelan, a private technology and healthcare investment banking, brokerage and asset management firm.
Mr. Whelan currently serves as Chairman of the Board of Directors of Aspen Technology, Inc., a public software and services company, and President and Co-founder of 13th Avenue Funding, a non-profit company. Mr. Whelan received a B.A. in history from Dartmouth College and an M.B.A. from the Stanford University Graduate School of Business.